Document is current

Article History

Accepted: 26 December 2022

First Online: 23 January 2023

Declarations

:

: The authors affirm that the patient provided informed consent for the publication of the images in Fig. a–c.

: RC, LG and YL obtained Pressio ICP sensors technical information from the manufacturer (Sophysa, Orsay, France). RC and YL are members of the executive committee and LG is a society member of the Neurocritical Care and Neuro Anesthesiology French-speaking society (ANARLF) (). RC received research funding from Sophysa and Clermont-Ferrand University hospital, consulting fees from Sophysa and Roche Diagnostics, meeting and travel support from UCB Pharma. LG received consulting fees, honorariums for presentation, travel reimbursement and research funding from Sophysa, research grants from “Les gueules cassées” foundation () and Ramsay Santé Research Foundation and research equipment from Atys Medical. YL received research funding from Sophysa, travel reimbursement and honoraria for presentations from Integra Lifesciences and a research grant from “Les gueules cassées” foundation ().

: None.

: Written informed consent for publication of their clinical details and/or clinical images was obtained from the patient/parent/guardian/ relative of the patient.